Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-18
DOI
10.1038/s41598-017-09009-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Conventional ELISA with Electrochemiluminescence Technology for Detection of Amyloid-β in Plasma
- (2017) Esther S. Oh et al. JOURNAL OF ALZHEIMERS DISEASE
- Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
- (2016) Sara Hall et al. MOVEMENT DISORDERS
- Tau Proteins in the Temporal and Frontal Cortices in Patients With Vascular Dementia
- (2015) Elizabeta B. Mukaetova-Ladinska et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
- (2015) Hlin Kvartsberg et al. Alzheimers Research & Therapy
- Detection and quantification of plasma amyloid-β by selected reaction monitoring mass spectrometry
- (2014) Jun Seok Kim et al. ANALYTICA CHIMICA ACTA
- Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
- (2014) Hana Přikrylová Vranová et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- CSF and Plasma Amyloid-β Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury
- (2014) Stefania Mondello et al. Scientific Reports
- Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
- (2013) Ming-Jang Chiu et al. ACS Chemical Neuroscience
- Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre
- (2013) Jon B. Toledo et al. BRAIN
- Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease
- (2013) Ming-Jang Chiu et al. HUMAN BRAIN MAPPING
- Cerebrospinal fluid biomarkers in Alzheimer’s disease, vascular dementia and ischemic stroke patients: a critical analysis
- (2013) Lisa Kaerst et al. JOURNAL OF NEUROLOGY
- New Assay for Old Markers-Plasma Beta Amyloid of Mild Cognitive Impairment and Alzheimer's Disease
- (2012) M.J. Chiu et al. Current Alzheimer Research
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
- (2010) M. Andersson et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started